Pando Bioscience
Gen-AI Designed Enzymes for Pharmaceutical Innovation
2023Founded
Team
5
current
Co-founders
1
current
Stage
Founded
Revenue · $1M · getlatka.com
Source for Founded
Profile coverage5 of 8 · missing Signals, Customers, Stack / tools · last run 8/10/2026
About
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.